MedPath

A Cognitive Behavioral Therapy Group Intervention to Increase HIV Testing and PrEP Use Among Latinx Sexual Minority Men

Not Applicable
Recruiting
Conditions
HIV
Interventions
Behavioral: CBT Coping Intervention
Registration Number
NCT04225832
Lead Sponsor
RAND
Brief Summary

This study consists of a randomized controlled trial (RCT) of a multi-session cognitive behavior therapy (CBT) group intervention that aims to improve HIV outcomes by increasing adaptive, effective coping responses to stigma from intersectional identities related to ethnicity, immigration status, sexual minority identity, HIV status, and PrEP use among Latinx sexual minority men (SMM).

Detailed Description

This study consists of a randomized controlled trial (RCT) of a multi-session cognitive behavior therapy (CBT) group intervention that aims to improve HIV outcomes by increasing adaptive, effective coping responses to stigma from intersectional identities related to ethnicity, immigration status, sexual minority identity, HIV status, and PrEP use among Latinx sexual minority men (SMM). We will test intervention effects on regular HIV testing and use of prevention strategies. The intervention was developed in partnership with community stakeholders at Bienestar Human Services, Inc., a Latinx-focused organization in Los Angeles County (LAC), CA. The intervention is flexible for use in community-based organizations, such as in ongoing support groups.

The Specific Aims are:

Aim 1. To conduct a randomized controlled trial of a culturally congruent cognitive behavior therapy group intervention for immigrant Latinx sexual minority men, to test intervention effects on regular HIV testing and PrEP uptake.

Aim 2. To examine mechanisms of intervention effects on regular HIV testing and PrEP uptake, including more effective coping (e.g., reduced internalized stigma).

Aim 3. To conduct a cost-effectiveness analysis of the intervention.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
300
Inclusion Criteria
  • at least 18 years-old
  • biologically male at birth
  • identify as male
  • identify as Latino
  • is an immigrant
  • report having sex with men in the past 12 months
  • report HIV-negative or unknown serostatus
  • anticipate being available for the next 12 months to attend study visits
  • able to interact and communicate in spoken Spanish or English.
Exclusion Criteria
  • HIV-positive
  • cisgender women
  • transgender women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CBT Coping InterventionCBT Coping InterventionThe intervention is an 8-session cognitive behavior therapy (CBT) group intervention that aims to improve HIV outcomes by increasing adaptive, effective coping responses to stigma from intersectional identities related to ethnicity, immigration status, sexual minority identity, HIV status, and PrEP among Latinx sexual minority men (SMM). The intervention sessions will address topics such as: understanding and coping with intersectional stigma, multiple identities (e.g., race/ethnicity, sexual orientation), medical mistrust, social support, and structural stigma. Intervention groups will be led by a trained facilitator (with expertise in group therapy with Latinx SMM) and a trained peer co-facilitator matched in identities with participants (Latinx SMM).
Primary Outcome Measures
NameTimeMethod
Proportion of participants who are HIV tested at least annuallyfrom baseline to 12-months

Participants report being tested for HIV at least once in the past 12 months

Proportion of participants who have taken PrEP in the past 12 monthsfrom baseline to 12-months

Participants report taking PrEP at any follow-up time-point

Secondary Outcome Measures
NameTimeMethod
Change in average level of adaptive coping, measured by the Brief COPEfrom baseline to 12-months

Average adaptive coping rating on the Brief COPE scale (higher=better coping; range=1-4)

Trial Locations

Locations (1)

Bienestar Human Services, Inc

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath